PTC Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good morning, and welcome to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm, and I want to thank everybody for joining us this week.
Our first presenting company is PTC Therapeutics. And it's my pleasure to welcome CEO, Stuart Peltz, to talk to us a little bit about the company. Just a quick formatting note. There is a Q&A session after the presentation. So I'm inviting everybody, all of our viewers to -- if you'd like to submit a question, I should say, just click the blue Ask a Question icon, and I'll work those questions and where appropriate. With that, Stu, let me pass it over to you for the presentation.
Well, thanks, Eric, and thanks for this introduction. I'm excited to provide an update on our achievements and upcoming milestones. Before I get started, I'll refer you to our forward-looking statements and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
